CROSS-PLATFORM CONCORDANCE ANALYSIS REVEALS ROBUST AND CLINICALLY RELEVANT GENE SIGNATURES IN BREAST CANCER
This study demonstrates that integrating two independent RNA-seq analytical workflows enables the identification of robust and clinically meaningful gene signatures in breast cancer, and provides a systematic approach for prioritizing candidate biomarkers and therapeutic targets in cancer transcriptomics.